zidovudine

Generic: zidovudine

Labeler: camber pharmaceuticals, inc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name zidovudine
Generic Name zidovudine
Labeler camber pharmaceuticals, inc.
Dosage Form TABLET
Routes
ORAL
Active Ingredients

zidovudine 300 mg/1

Manufacturer
Camber Pharmaceuticals, Inc.

Identifiers & Regulatory

Product NDC 31722-509
Product ID 31722-509_fbbb4305-5ef7-b4b5-e053-6294a90a278c
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA090092
Listing Expiration 2026-12-31
Marketing Start 2008-04-25

Pharmacologic Class

Established (EPC)
human immunodeficiency virus nucleoside analog reverse transcriptase inhibitor [epc]
Mechanism of Action
nucleoside reverse transcriptase inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 31722509
Hyphenated Format 31722-509

Supplemental Identifiers

RxCUI
199663
UNII
4B9XT59T7S
NUI
N0000175462 N0000009947

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name zidovudine (source: ndc)
Generic Name zidovudine (source: ndc)
Application Number ANDA090092 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 300 mg/1
source: ndc
Packaging
  • 12 BOTTLE in 1 CASE (31722-509-60) / 60 TABLET in 1 BOTTLE
source: ndc

Packages (1)

31722-509-60 12 BOTTLE in 1 CASE (31722-509-60) / 60 TABLET in 1 BOTTLE

Ingredients (1)

zidovudine (300 mg/1)

Linked Drug Pages (1)

Zidovudine ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "fbbb4305-5ef7-b4b5-e053-6294a90a278c", "openfda": {"nui": ["N0000175462", "N0000009947"], "unii": ["4B9XT59T7S"], "rxcui": ["199663"], "spl_set_id": ["ca9f0c57-fc8b-4da4-a987-0fc52b7fd4f4"], "pharm_class_epc": ["Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]"], "pharm_class_moa": ["Nucleoside Reverse Transcriptase Inhibitors [MoA]"], "manufacturer_name": ["Camber Pharmaceuticals, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "12 BOTTLE in 1 CASE (31722-509-60)  / 60 TABLET in 1 BOTTLE", "package_ndc": "31722-509-60", "marketing_start_date": "20080425"}], "brand_name": "Zidovudine", "product_id": "31722-509_fbbb4305-5ef7-b4b5-e053-6294a90a278c", "dosage_form": "TABLET", "pharm_class": ["Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Nucleoside Reverse Transcriptase Inhibitors [MoA]"], "product_ndc": "31722-509", "generic_name": "Zidovudine", "labeler_name": "Camber Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Zidovudine", "active_ingredients": [{"name": "ZIDOVUDINE", "strength": "300 mg/1"}], "application_number": "ANDA090092", "marketing_category": "ANDA", "marketing_start_date": "20080425", "listing_expiration_date": "20261231"}